Stief Thomas W
Institute of Laboratory Medicine and Pathobiochemistry, University Hospital Marburg, Germany.
Blood Coagul Fibrinolysis. 2012 Jun;23(4):296-8. doi: 10.1097/MBC.0b013e328351d99e.
Contact activation of hemostasis is of great clinical importance. Intrinsic coagulation starts upon blood matrix change, resulting in activation of factor XII (F XII) to F XIIa and/or of prekallikrein to kallikrein. The intrinsic system is very complex. There are many reactions that can increase or decrease the generation of F Xa/thrombin. Currently, there are two main trigger types that activate the intrinsic system: (delta)-negatively charged molecules and lipophilic molecules. Recently, it was shown that the stimulation of thrombin generation by (delta)-negatively charged molecules depends on their maximal plasma concentration prior to plasma dilution. The questions arise whether this is also true for lipophilic triggers. Fifty-microliter frozen/thawed pooled normal platelet-poor citrated plasma (PNP) were supplemented with up to 5% (final concentration) hexane, followed by repetitive 1 + 1 dilutions on polystyrene U-wells microtiter plates of high quality (Brand, Wertheim, Germany; article number 781600). Immediately thereafter, the recalcified coagulation activity assay was started and the approximate 200% stimulatory concentrations (approx. SC200s) on intrinsic thrombin generation were determined, the 100% control being unsupplemented PNP. The higher the maximal concentration of hexane prior to dilution, the higher the approx. SC200. If the maximal hexane concentration prior to dilution was higher than 2%, PNP had an approx. SC200 of 0.1-0.2% (8-15 mmol/l) hexane. At maximal hexane concentrations prior to dilution in the range of 0.1-1%, the approx. SC200 decreased 10-fold to about 0.01-0.02%. Up to about 0.1% maximal hexane concentration prior to dilution the corresponding approx. SC200 of hexane on intrinsic thrombin generation was 0.003-0.01% (0.2-0.8 mmol/l). Both main types of contact triggers - negatively charged or lipophilic molecules - have a peculiar behavior respective to maximal plasma concentration/thrombin generation: if the maximal plasma concentration of the trigger prior to plasma dilution is high, then the thrombin generating system needs rather high amounts of triggers to reach approx. SC200; and, if the maximal plasma concentration of the trigger prior to dilution is low, then thrombin is easily generated with a low approx. SC200. This means that the plasmatic F XII/prekallikrein/HMWK system could be inhibited by high plasma concentrations of any trigger and this inhibition cannot be reversed by plasma dilution. To study the action of drugs on the intrinsic system of plasma, plasma should be supplemented with the respective drug at maximal concentrations that are in the range of the maximal blood concentrations obtained in clinical medicine.
凝血的接触激活具有重要的临床意义。内源性凝血始于血液基质的改变,导致因子 XII(F XII)激活为 F XIIa 和/或前激肽释放酶激活为激肽释放酶。内源性系统非常复杂。有许多反应可增加或减少 F Xa/凝血酶的生成。目前,激活内源性系统的主要触发类型有两种:δ - 带负电荷分子和亲脂性分子。最近研究表明,δ - 带负电荷分子对凝血酶生成的刺激作用取决于其在血浆稀释前的最大血浆浓度。那么对于亲脂性触发物来说是否也是如此呢?向 50 微升冷冻/解冻的混合正常少血小板枸橼酸盐血浆(PNP)中添加高达 5%(终浓度)的己烷,然后在高质量的聚苯乙烯 U 型孔微量滴定板(德国韦特海姆布兰德公司;货号 781600)上进行重复的 1 + 1 稀释。此后立即开始重新钙化凝血活性测定,并确定内源性凝血酶生成的近似 200%刺激浓度(近似 SC200),未添加的 PNP 作为 100%对照。稀释前己烷的最大浓度越高,近似 SC200 越高。如果稀释前己烷的最大浓度高于 2%,PNP 的近似 SC200 为 0.1 - 0.2%(8 - 15 毫摩尔/升)己烷。在稀释前己烷最大浓度为 0.1 - 1%的范围内,近似 SC200 降低 10 倍至约 0.01 - 0.02%。在稀释前己烷最大浓度高达约 0.1%时,己烷对内源性凝血酶生成的相应近似 SC200 为 0.003 - 0.01%(0.2 - 0.8 毫摩尔/升)。两种主要的接触触发物类型——带负电荷或亲脂性分子——在最大血浆浓度/凝血酶生成方面都有特殊行为:如果血浆稀释前触发物的最大血浆浓度较高,那么凝血酶生成系统需要相当高剂量的触发物才能达到近似 SC200;而如果稀释前触发物的最大血浆浓度较低,那么以较低的近似 SC200 就能轻松生成凝血酶。这意味着血浆中任何触发物的高浓度都可能抑制血浆中的 F XII/前激肽释放酶/高分子量激肽原系统,且这种抑制不能通过血浆稀释逆转。为了研究药物对内源性血浆系统的作用,应在临床医学中获得的最大血药浓度范围内,以最大浓度向血浆中添加相应药物。